On May 20, 2025, McKesson Corporation announced the closing of a $2 billion notes offering, which includes 4.650% Notes due 2030, 4.950% Notes due 2032, and 5.250% Notes due 2035, to fund a 70% stake acquisition in Community Oncology Revitalization Enterprise Ventures, LLC. The transaction is expected to enhance McKesson's strategic operations in oncology service delivery.